• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源单链抗体可抑制1型人类免疫缺陷病毒(HIV-1)的复制。

Human single-chain antibodies inhibit replication of human immunodeficiency virus type 1 (HIV-1).

作者信息

Liu Fangbing, Kumar Mukesh, Ma Qiangzhong, Duval Mark, Kuhrt David, Junghans Richard, Posner Marshall, Cavacini Lisa

机构信息

Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

出版信息

AIDS Res Hum Retroviruses. 2005 Oct;21(10):876-81. doi: 10.1089/aid.2005.21.876.

DOI:10.1089/aid.2005.21.876
PMID:16225415
Abstract

The F240 human monoclonal antibody specifically recognizes the disulfide loop-bonded immunodominant epitope of gp41 spanning residues 592-606 and expressed broadly on HIV-1 primary isolates. Despite broad reactivity with native virions and HIV-infected cells, the antibody fails to neutralize infection. However, cytoplasmic expression of single-chain antibody (scFv) directed against gp41 of HIV-1 provides a rationale means to inhibit the maturation of envelope protein. The variable regions of the heavy chain and light chain of human monoclonal antibody were amplified by PCR and linked by a 15 amino acid (GGSGS)3 linker in an orientation of VL-linker-VH and retroviral expression vectors were constructed to simultaneously express F240 scFv and eGFP to facilitate selection of scFv-producing cells. Incorporation of a human immunoglobulin signal sequence directed secretion of the F240 scFv (s-scFv) while an otherwise identical vector lacked this sequence (scFv) resulting in intracellular expression of scFv. Transduced human CD4+ H9 T cells were challenged with HIV. While both secreted and nonsecreted F240 scFv inhibited viral production, secretory F240 scFv was more potent. Thus, this novel approach to direct expression of a nonneutralizing scFv using the Ig signal sequence suggests that targeted therapy using antibodies to conserved, highly expressed epitopes may result in a decrease in viral production due to a reduction of viral assembly and/or transport and expression.

摘要

F240人源单克隆抗体特异性识别gp41中由二硫键环连接的免疫显性表位,该表位跨越592 - 606位氨基酸残基,在HIV-1原代分离株上广泛表达。尽管该抗体与天然病毒粒子和HIV感染细胞具有广泛反应性,但它无法中和感染。然而,针对HIV-1 gp41的单链抗体(scFv)的细胞质表达为抑制包膜蛋白成熟提供了一种合理的方法。通过PCR扩增人源单克隆抗体重链和轻链的可变区,并通过一个15个氨基酸(GGSGS)3的接头以VL-接头-VH的方向连接,构建逆转录病毒表达载体以同时表达F240 scFv和增强绿色荧光蛋白(eGFP),便于选择产生scFv的细胞。加入人免疫球蛋白信号序列可指导F240 scFv(s-scFv)的分泌,而一个除缺少该序列(scFv)外其他相同的载体则导致scFv在细胞内表达。用HIV攻击转导的人CD4 + H9 T细胞。虽然分泌型和非分泌型F240 scFv均能抑制病毒产生,但分泌型F240 scFv的效果更强。因此,这种利用Ig信号序列直接表达非中和性scFv的新方法表明,使用针对保守的、高表达表位的抗体进行靶向治疗可能会由于病毒组装和/或运输及表达的减少而导致病毒产生量下降。

相似文献

1
Human single-chain antibodies inhibit replication of human immunodeficiency virus type 1 (HIV-1).人源单链抗体可抑制1型人类免疫缺陷病毒(HIV-1)的复制。
AIDS Res Hum Retroviruses. 2005 Oct;21(10):876-81. doi: 10.1089/aid.2005.21.876.
2
Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41.与1型人类免疫缺陷病毒糖蛋白41免疫显性区域反应的人单克隆抗体的功能及分子特征
AIDS Res Hum Retroviruses. 1998 Sep 20;14(14):1271-80. doi: 10.1089/aid.1998.14.1271.
3
Development of functional human monoclonal single-chain variable fragment antibody against HIV-1 from human cervical B cells.从人宫颈B细胞开发抗HIV-1的功能性人单克隆单链可变片段抗体。
Hybrid Hybridomics. 2003 Apr;22(2):97-108. doi: 10.1089/153685903321948021.
4
Cells transfected with a non-neutralizing antibody gene are resistant to HIV infection: targeting the endoplasmic reticulum and trans-Golgi network.转染非中和抗体基因的细胞对HIV感染具有抗性:靶向内质网和反式高尔基体网络。
J Immunol. 1998 Feb 1;160(3):1489-96.
5
Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.在gp41免疫显性区域内一种新型1型人类免疫缺陷病毒可中和表位的特性分析
Virology. 2000 Apr 25;270(1):135-45. doi: 10.1006/viro.2000.0269.
6
Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.针对HIV-1外膜糖蛋白gp120的单链抗体的工程化及功能评估
Clin Exp Immunol. 2005 Jul;141(1):72-80. doi: 10.1111/j.1365-2249.2005.02826.x.
7
A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGN.一种非中和性抗1型HIV抗体在1型HIV易感细胞表面表达时会转变为广泛中和抗体。II. 对DC-SIGN捕获并转移的1型HIV的抑制作用。
AIDS Res Hum Retroviruses. 2006 Sep;22(9):874-83. doi: 10.1089/aid.2006.22.874.
8
The neutralization properties of a HIV-specific antibody are markedly altered by glycosylation events outside the antigen-binding domain.HIV特异性抗体的中和特性会因抗原结合域外的糖基化事件而发生显著改变。
J Immunol. 2007 Jun 1;178(11):7132-8. doi: 10.4049/jimmunol.178.11.7132.
9
Design and intracellular activity of a human single-chain antibody to human immunodeficiency virus type 1 conserved gp41 epitope.针对人免疫缺陷病毒1型保守gp41表位的人单链抗体的设计及细胞内活性
J Virol. 2000 Jun;74(12):5712-5. doi: 10.1128/jvi.74.12.5712-5715.2000.
10
Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.针对人类免疫缺陷病毒1型包膜蛋白主要中和结构域的小鼠/人嵌合单克隆抗体(Cβ1)的特性分析
AIDS Res Hum Retroviruses. 1992 Jun;8(6):1107-15. doi: 10.1089/aid.1992.8.1107.

引用本文的文献

1
CD4-Binding Site Directed Cross-Neutralizing scFv Monoclonals from HIV-1 Subtype C Infected Indian Children.来自感染HIV-1 C亚型的印度儿童的CD4结合位点定向交叉中和单链抗体片段单克隆抗体
Front Immunol. 2017 Nov 15;8:1568. doi: 10.3389/fimmu.2017.01568. eCollection 2017.
2
Reduction of HIV-1 infectivity through endoplasmic reticulum-associated degradation-mediated Env depletion.通过内质网相关降解介导的Env耗竭降低HIV-1感染性。
J Virol. 2015 Mar;89(5):2966-71. doi: 10.1128/JVI.02634-14. Epub 2014 Dec 24.
3
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.
甘露糖特异性凝集素 griffithsin 与 HIV-1 gp120 的结合暴露了 CD4 结合位点。
J Virol. 2011 Sep;85(17):9039-50. doi: 10.1128/JVI.02675-10. Epub 2011 Jun 22.